essential information

Terms and conditions associated with the VIA programme.

financialBACK TO TOP

IADDITIONAL FUNDING
Applicable projects will have no existing funding from similar or profit making bodies. For bodies awarded a grant, no additional funding for the specific research will be permitted.
IIAUTHORISED EXPENSES
The following expenses will be permitted:
  • Grant for hours of work which are specified in the project
  • Supplies and consumables necessary to fulfil the project's aims
  • Travel expenses directly related to the implementation of the project
  • Costs associated with the publication of the research
  • Up to 20% of overheads.
IIIUNAUTHORISED EXPENSES
The following expenses listed below will not be permitted (but are not limited to):
  • Salaries
  • Travel and/or housing related to sabbaticals
  • Purchase or rental of office equipment
  • Fees for tuition
  • Membership dues, congress/meeting registrations, subscriptions, books or journals.
IVFUNDS AND FINANCIAL REPORTS

A contract will be agreed between Vertex and the grant recipient centre and all grant recipients are required to submit a statement from their institution stating that the grant has been received. In the event that unexpended funds remain at the end of the funding period, these funds must be returned to the VIA programme.


A final financial report will be due 60 days after the end of the funding period reconciling the proposed budget with the actual expenditure.


The VIA Committee will be responsible for the selection and evaluation of the project, while Vertex will be responsible for payment and contractual matters with the project centre.

VDISBURSEMENT OF FUNDS

As a rule, the projects will be funded in equal instalments: an advance payment will be transferred on signing the contract and subsequent instalments will be transferred on a bi-annual basis provided that the interim reports are accepted by the VIA Committee.

VIMULTIPLE GRANTS
Applicants may only receive one grant from the VIA programme per annual cycle.
VIIMULTIPLE APPLICATIONS FROM THE SAME INSTITUTION
More than one application from the same institution (i.e. university, hospital) is permitted. However, multiple applications from the same group of researchers at such an institute (i.e. those working in the same laboratory or department) are not permitted.
VIIIMULTI-CENTRE APPLICATIONS
Applications for multi-centre projects are permitted, but where this is the case a lead centre must be nominated. The application should be submitted by the principal investigator centre.
IXCHANGE IN GRANT RECIPIENT’S STATUS
The transfer of a grant to another institution will be at the sole discretion of the VIA programme and a new contract with the centre may be required.
XPROGRESS AND FINAL REPORTS
Progress reports will be expected of the selected project with the awarded project team providing interim 6-month evidence of progress to the VIA Committee. In addition, awardees will be required to provide final reports upon completion of the funded projects. The VIA Committee will confirm the specific reporting requirements at the selection of the final project.
XITERMINATION OF SUPPORT
If the grant recipient fails to comply with any terms of the agreement then Vertex reserves the right to remove funding.

commercialBACK TO TOP

IFOR-PROFIT ORGANISATIONS

For-profit organisations are not allowed to apply to the VIA programme (e.g. pharmaceutical companies, homecare companies, health maintenance organisations, etc.). The exceptions are research laboratories and academic institutions that may exist as part of a hospital that is run for profit.


If in doubt about eligibility, candidates should contact the VIA Secretariat who will seek guidance.

IICOMMERCIALISATION RIGHTS
Vertex may ask for a right of first refusal to obtain an exclusive worldwide license to any technology invented or improved under the grant. In such cases, Vertex will negotiate with the appropriate party to seek an appropriate arrangement.
IIIINVENTIONS AND PATENTS

Researchers funded by the VIA programme may produce inventions that should be patented. The investigator and/or the institution will own the patent according to arrangements they have made with each other.

The grant recipient is responsible for ensuring that intellectual property is protected by assuring confidentiality until Vertex has had the opportunity to evaluate the research funded by the VIA programme for potential inventions. Vertex will have a minimum of 30 days and a maximum of 60 days to evaluate any research funded by the VIA programme for inventions and patentability before the applicant is free to publish the information. In this case, ‘publishing’ includes any oral presentation and electronic information transfer in addition to the publication of manuscripts and abstracts. If Vertex decides that an invention should be patented, the investigator may not publish anything until the relevant patent applications have been filed.

otherBACK TO TOP

IRECOMBINANT MOLECULES, ANIMAL AND HUMAN SUBJECTS

Applicants requesting a grant to carry out research with recombinant molecules and/or animal or human subjects must obtain and show proof of the required approvals from the centre, local or government authority. If an applicant's institute does not require special permission for using recombinant molecules, then this must be communicated to the VIA programme administrator. Vertex can provide assistance with this process if requested by the investigator.


The VIA programme administrator must receive copies of appropriate permissions before any grant funds will be disbursed.


The applicant's institution has responsibility for ensuring that the rights of any human subjects are upheld and that animals are cared for in a humane manner.

IIPUBLICATIONS

Subject to the limitations in the ‘Inventions and Patents’ section above, the VIA programme strongly encourages the grant recipients to publish work carried out under a grant. This includes abstract submissions to congresses. Where a publication is not granted, proof of application is sufficient demonstration. An effort for publication submission must be shown.


Grant recipients must acknowledge the receipt of funding from the VIA programme in publications and abstracts describing research conducted with awards made by the VIA programme.

contact us

contact us

Should you have any queries regarding the VIA programme or the process of submitting a proposal, please complete the online form below.

EMAIL: jeremy.williams@chameleon-uk.com

NAME
EMAIL
CONFIRM EMAIL
COMMENT/QUESTION